All Articles

One year in, global broker ATFX expands in Phnom Penh, backed by regulators. The move signals a major shift for Cambodia's maturing financial markets.

Zevia PBC appoints beverage industry veteran Alexandre Ruberti as CEO, pivoting from turnaround to 'accelerated execution' at a critical inflection point.

A green finance firm is investing in gas-powered data centers. Stephen Miller analyzes the $15M deal that reveals the pragmatic, and controversial, future of AI.

With a new sales head from Citi, OTC Markets is betting on deep industry ties to accelerate its expansion into new platforms and 24-hour trading.

Dominari Securities' successful $200M fund for the SpaceX IPO isn't just a trade; it's a masterclass in the new mechanics of power and profit on Wall Street.

A partnership born from a military hackathon shows how rapid prototyping is shattering old procurement models and accelerating autonomous defense solutions.

Venu Holding Corp. is betting big on sale-leasebacks to fund its rapid expansion, but a look at its financials reveals a high-stakes balancing act.

Malicious AI now writes its own malware and runs attacks autonomously. As the threat accelerates, a new generation of defensive AI is the only thing standing in the way.

With its new Colorado facility, USA Rare Earth aims to produce vital heavy rare earths, a critical step in the West's high-stakes bid to build a secure supply chain.

Rain's new integrated loyalty platform aims to make stablecoin cards mainstream, offering partners a way to drive engagement and a proven 25% spending lift.

Tiziana Life Sciences’ chairman just increased his massive stake. We analyze if this is a vote of confidence in its novel MS drug or a risky bet on a fragile biotech.

Trading Technologies partners with ICE to launch a new fixed income EMS, aiming to shatter market silos with a unified multi-asset trading experience.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Aurora Mobile integrates ShengShu's potent Vidu model, a strategic maneuver to challenge giants like OpenAI and Google by offering a unified, production-ready AI video platform.

A missed clinical trial endpoint is often the end. For Elicio Therapeutics, a deeper data dive reveals a potential path forward for a high-need patient group.

The deal showcases a masterful exit in a tough market and signals deeper shifts in the pharma R&D landscape, where specialized research partners are king.

Ricola bets big, moving beyond the medicine cabinet with new functional drops. Can the heritage brand reinvent itself for the modern wellness consumer?

New data reveals an oral drug can halt severe hereditary angioedema attacks in minutes, promising a future free from needles and fear for thousands.

Federal, provincial, and municipal leaders unite in Quebec City, signaling a new, systems-based approach to the housing crisis. Is this the model for a nation?

The 18th Straits Forum promotes 'people-to-people' ties, but Taipei calls it a political ploy. What's at stake for the people caught in between?